Clinical Trials Directory

Trials / Unknown

UnknownNCT05393453

Prognosis of Patients With Acute-on-chronic Liver Failure

The Investigate Outcomes and Prognostic Factors of Patients With Acute-on-chronic Liver Failure

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Xiangya Hospital of Central South University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

Patients with Acute on Chronic Liver Failure (ACLF) have high short-term mortality. The use of a severity score could define the patient's prognosis. This study mainly prospectively analyze the clinical data of patients with chronic liver disease related acute liver failure admitted to the department of infectious diseases, Xiangya Hospital of Central South University, to analyze the prognosis of patients with chronic liver disease related acute on-chronic liver failure in Central South China. No additional interventions other than routine treatment will be added.

Detailed description

Patients with Acute on Chronic Liver Failure (ACLF) have high short-term mortality. The use of a severity score could define the patient's prognosis and would help determine in whom the treatment is effective. This study mainly prospectively analyze the clinical data of patients with chronic liver disease related acute liver failure admitted to the department of infectious diseases, Xiangya Hospital of Central South University, to analyze the short-time and relatively long-term prognosis of patients with chronic liver disease related acute on-chronic liver failure. This is an observational study. All subjects will receive the currently recognized routine treatment of liver failure and corresponding etiological treatment if needed. The researchers will collect various clinical examination indexes of the subjects in the process of diagnosis and treatment, including but not limited to blood routine, biochemistry, coagulation function, liver imaging, therapeutic drugs, etc. Complications and prognosis of patients will be recorded. Blood samples, urine and stool samples of all subjects will be taken after enrollment and stored for probably testing in the future. This study has no additional intervention and treatment for subjects. All subjects will sign informed consent.

Conditions

Timeline

Start date
2022-06-01
Primary completion
2024-06-01
Completion
2025-06-01
First posted
2022-05-26
Last updated
2022-06-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05393453. Inclusion in this directory is not an endorsement.